Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTS,S/AS01B Malaria Vaccine Challenge Study
NCT01857869Phase 2Completed
- Sponsor
- GSK
- Start
- May 2013
- Primary completion
- Mar 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of RTS,S in malaria (3 arms), sponsored by GSK. Primary endpoint: Number of Subjects With Plasmodium Falciparum Parasitemia Defined by a Positive Blood Slide. Started May 2013; status: completed.
02
Drugs
RTS,S
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01857869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01857869.